Skip to main content
. 2022 Feb 21;10(2):506. doi: 10.3390/biomedicines10020506

Figure 2.

Figure 2

Modified from Beasley et al. [26] showing CNV-profiles derived from the primary tumor (FFPE tissue) and CTCs isolated from 10 mL peripheral blood of the same patient after whole genome amplification and shallow Whole Genome Sequencing (genomic coverage: 0.37×, 0.30× and 0.26×, respectively).